Clincosm LogoSign in Get a demo

myelofibrosis

Showing NaN - NaN of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +13 more
Jan 10, 2023

Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

Recruiting
  • Myelofibrosis; Anemia
  • +5 more
  • Jacksonville, Florida
  • +6 more
Jan 3, 2023

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Berkeley, California
  • +176 more
Dec 1, 2022

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Anchorage, Alaska
  • +172 more
Dec 1, 2022

Myelofibrosis Trial in Worldwide (PXS-5505)

Recruiting
  • Myelofibrosis
  • Birmingham, Alabama
  • +19 more
Nov 28, 2022

Myelofibrosis Trial in Worldwide (GB2064)

Recruiting
  • Myelofibrosis
  • Houston, Texas
  • +11 more
Nov 23, 2022

Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Overlap Syndrome Trial in Worldwide

Recruiting
  • Myelofibrosis
  • +5 more
  • Birmingham, Alabama
  • +27 more
Oct 17, 2022

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +148 more
Oct 10, 2022

Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Long-term Follow-up
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)

Active, not recruiting
  • Myelofibrosis
  • Middletown, New Jersey
  • +6 more
Aug 23, 2022

Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

Recruiting
  • Myeloproliferative Disorders
  • +4 more
  • La Jolla, California
  • +184 more
Aug 22, 2022

Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +165 more
Aug 19, 2022

Myelofibrosis Trial in Gilbert, Houston (APG-1252, Ruxolitinib)

Withdrawn
  • Myelofibrosis
  • Gilbert, Arizona
  • +1 more
Jul 8, 2022

Myelofibrosis Trial in Houston (CK0804)

Not yet recruiting
  • Myelofibrosis
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jun 28, 2022

Myelofibrosis Trial in Worldwide (TL-895)

Recruiting
  • Myelofibrosis
  • Aurora, Colorado
  • +65 more
Jun 2, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +12 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +2 more
Feb 17, 2022

Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

Terminated
  • Double Cord Blood Transplant
  • +8 more
  • TXA127 300 mcg/kg/day
  • TXA127 1000 mcg/kg/day
  • Houston, Texas
    MD Anderson Cancer Center
Dec 7, 2020

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in United States (PU-H71, Ruxolitinib)

Terminated
  • Myelofibrosis
  • +3 more
  • New Haven, Connecticut
  • +9 more
Oct 19, 2020

Leukemia, Myelofibrosis, Anemia Trial in Houston (Rigosertib, Questionnaire)

Terminated
Has Results
  • Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 5, 2020

Myelofibrosis Trial in United States (Simtuzumab, Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Scottsdale, Arizona
  • +6 more
Jun 17, 2020

Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis Trial in Worldwide (Pomalidomide, Prednisone, Placebo

Completed
Has Results
  • Myelofibrosis With Myeloid Metaplasia
  • +2 more
  • Los Angeles, California
  • +10 more
Nov 7, 2019

Myelofibrosis Trial in Houston (Lenalidomide, Prednisone)

Completed
Has Results
  • Myelofibrosis
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 18, 2019

Myelofibrosis Trial in Houston (Busulfan, Fludarabine, Thymoglobulin (ATG))

Completed
Has Results
  • Myelofibrosis
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 13, 2019